Cigna Group $CI Stake Lessened by Platinum Investment Management Ltd.

Platinum Investment Management Ltd. cut its stake in Cigna Group (NYSE:CI) by 10.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 810 shares of the health services provider’s stock after selling 92 shares during the period. Platinum Investment Management Ltd.’s holdings in Cigna Group were worth $268,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Modern Wealth Management LLC lifted its stake in Cigna Group by 91.3% during the first quarter. Modern Wealth Management LLC now owns 3,130 shares of the health services provider’s stock valued at $1,030,000 after purchasing an additional 1,494 shares during the last quarter. Acadian Asset Management LLC lifted its stake in Cigna Group by 277.5% during the first quarter. Acadian Asset Management LLC now owns 8,274 shares of the health services provider’s stock valued at $2,718,000 after purchasing an additional 6,082 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in Cigna Group during the first quarter valued at approximately $431,000. NBC Securities Inc. acquired a new stake in Cigna Group during the first quarter valued at approximately $123,000. Finally, Integrity Alliance LLC. acquired a new stake in Cigna Group during the first quarter valued at approximately $617,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.70% of the company’s stock.

Cigna Group Stock Performance

Shares of CI opened at $291.36 on Thursday. The company’s fifty day moving average is $292.05 and its 200-day moving average is $310.02. Cigna Group has a 12 month low of $256.89 and a 12 month high of $358.88. The firm has a market cap of $77.77 billion, a price-to-earnings ratio of 15.90, a price-to-earnings-growth ratio of 0.84 and a beta of 0.46. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. During the same period last year, the business posted $6.72 EPS. Cigna Group’s revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were paid a $1.51 dividend. The ex-dividend date was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is presently 32.97%.

Analyst Upgrades and Downgrades

CI has been the subject of several recent research reports. Guggenheim reissued a “buy” rating and set a $350.00 target price (down from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Barclays upped their price target on shares of Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a research report on Thursday, September 4th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, September 13th. Robert W. Baird set a $372.00 price target on shares of Cigna Group in a research report on Thursday, August 14th. Finally, Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the company a “buy” rating in a research report on Tuesday, August 5th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $371.81.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.